Krystal Biotech Inc Earnings

Krystal Biotech Inc’s revenue jumped 94.88% since last year same period to $88.18Mn in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -3.24% fall in its revenue since last 3-months.

Krystal Biotech Inc’s net profit jumped 3734.01% since last year same period to $35.73Mn in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -21.43% fall in its net profits since last 3-months.

Krystal Biotech Inc’s net profit margin jumped 1867.38% since last year same period to 40.52% in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -18.8% fall in its net profit margins since last 3-months.

Krystal Biotech Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 35.43.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 1.43 - a 10% jump from last quarter’s estimates.

Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 1.43.

Krystal Biotech Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Krystal Biotech Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.